MR-Untersuchungen bei Patienten mit Herzschrittmachern und implantierbaren Kardioverter‑Defibrillatoren

Roguin A, Schwitter J, Vahlhaus C, Lombardi M, Brugada J, Vardas P et al (2008) Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 10(3):336–346

Sommer T, Naehle CP, Yang A, Zeijlemaker V, Hackenbroch M, Schmiedel A et al (2006) Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation 114(12):1285–1292

Nazarian S, Hansford R, Roguin A, Goldsher D, Zviman MM, Lardo AC et al (2011) A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med 155(7):415–424

Nazarian S, Halperin HR (2009) How to perform magnetic resonance imaging on patients with implantable cardiac arrhythmia devices. Heart Rhythm 6(1):138–143

Roguin A, Zviman MM, Meininger GR, Rodrigues ER, Dickfeld TM, Bluemke DA et al (2004) Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation 110(5):475–482

Nazarian S, Beinart R, Halperin HR (2013) Magnetic resonance imaging and implantable devices. Circ Arrhythm Electrophysiol 6(2):419–428

Sommer T, Vahlhaus C, Lauck G, von Smekal A, Reinke M, Hofer U et al (2000) MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology 215(3):869–879

Luechinger R, Duru F, Scheidegger MB, Boesiger P, Candinas R (2001) Force and torque effects of a 1.5-Tesla MRI scanner on cardiac pacemakers and ICDs. Pacing Clin Electrophysiol 24(2):199–205

Luechinger R, Duru F, Zeijlemaker VA, Scheidegger MB, Boesiger P, Candinas R (2002) Pacemaker reed switch behavior in 0.5, 1.5, and 3.0 Tesla magnetic resonance imaging units: are reed switches always closed in strong magnetic fields? Pacing Clin Electrophysiol 25(10):1419–1423

Luechinger R, Zeijlemaker VA, Pedersen EM, Mortensen P, Falk E, Duru F et al (2005) In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J 26(4):376–383

Tandri H, Zviman MM, Wedan SR, Lloyd T, Berger RD, Halperin H (2008) Determinants of gradient field-induced current in a pacemaker lead system in a magnetic resonance imaging environment. Heart Rhythm 5(3):462–468

Naehle CP, Meyer C, Thomas D, Remerie S, Krautmacher C, Litt H et al (2008) Safety of brain 3‑T MR imaging with transmit-receive head coil in patients with cardiac pacemakers: pilot prospective study with 51 examinations. Radiology 249(3):991–1001

Naehle CP, Zeijlemaker V, Thomas D, Meyer C, Strach K, Fimmers R et al (2009) Evaluation of cumulative effects of MR imaging on pacemaker systems at 1.5 Tesla. Pacing Clin Electrophysiol 32(12):1526–1535

Schmiedel A, Hackenbroch M, Yang A, Nahle CP, Skowasch D, Meyer C et al (2005) Magnetic resonance imaging of the brain in patients with cardiac pacemakers. Experimental and clinical investigations at 1.5 Tesla. Rofo 177(5):731–744

Strach K, Naehle CP, Muhlsteffen A, Hinz M, Bernstein A, Thomas D et al (2010) Low-field magnetic resonance imaging: increased safety for pacemaker patients? Europace 12(7):952–960

Nazarian S, Roguin A, Zviman MM, Lardo AC, Dickfeld TL, Calkins H et al (2006) Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation 114(12):1277–1284

Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K (2004) Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 43(7):1315–1324

Mollerus M, Albin G, Lipinski M, Lucca J (2008) Cardiac biomarkers in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan. Pacing Clin Electrophysiol 31(10):1241–1245

Mollerus M, Albin G, Lipinski M, Lucca J (2010) Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions. Europace 12(7):947–951

Nordbeck P, Weiss I, Ehses P, Ritter O, Warmuth M, Fidler F et al (2009) Measuring RF-induced currents inside implants: Impact of device configuration on MRI safety of cardiac pacemaker leads. Magn Reson Med 61(3):570–578

Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA et al (2013) ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 15(8):1070–1118

Sommer T, Luechinger R, Barkhausen J, Gutberlet M, Quick HH, Fischbach K (2015) German Roentgen Society statement on MR imaging of patients with cardiac pacemakers. Rofo 187(9):777–787

Markewitz A (2013) Annual Report 2011 of the German pacemaker and defibrillator register: Section pacemakers and AQUA-Institute for Applied Quality Improvement and Research in Health Care. Herzschrittmacherther Elektrophysiol 24(4):249–274

Raatikainen MJ, Arnar DO, Zeppenfeld K, Merino JL, Kuck KH, Hindricks G (2015) Current trends in the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology member countries: 2015 report from the European Heart Rhythm Association. Europace 17(Suppl 4):iv1–72

Levine GN, Gomes AS, Arai AE, Bluemke DA, Flamm SD, Kanal E et al (2007) Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 116(24):2878–2891

Naehle CP, Strach K, Thomas D, Meyer C, Linhart M, Bitaraf S et al (2009) Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 54(6):549–555

Gimbel JR (2009) Unexpected asystole during 3 T magnetic resonance imaging of a pacemaker-dependent patient with a modern pacemaker. Europace 11:1241–1242

Irnich W, Irnich B, Bartsch C et al (2005) Do we need pacemakers resistant to magnetic resonance imaging? Europace 7:353–365

Wilkoff BL, Bello D, Taborsky M et al (2011) Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm 8:65–73

Gold MR, Sommer T, Schwitter J et al (2015) Full-body MRI in patients with an implantable cardioverter-defibrillator: primary results of a randomized study. J Am Coll Cardiol 65(24):2581–2588

Awad K, Griffin J, Crawford TC et al (2015) Clinically safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5 T magnetic resonance imaging scanning conditions. Heart Rhythm 12(10):2155–2161

Bailey WM, Mazur A, McCotter C et al (2016) Clinical safety of the ProMRI pacemaker system in patients subjected to thoracic spine and cardiac 1.5 T magnetic resonance imaging conditions. Heart Rhythm 13(2):464–471